News_第12页_Shenyang Dasan Pharmaceutical Technology Co., Ltd.

Home


Distinguish	Title	Data
Industry	Four Departments Jointly Issue Announcement on the Good Agricultural Practice for Chinese Herbal Medicines	2022-03-18
Industry	The Sixth Round of National Centralized Procurement: These Provinces and Cities to Implement the Results	2022-03-15
Company	Glamorous Women, Shining at Work	2022-03-08
Industry	Novavax COVID-19 vaccine NVX-CoV2373 shows significant efficacy in Phase 3 clinical trial in the UK	2022-03-04
Industry	Guiding Opinions on the Applicable Principles of Article 117, Paragraph 2 of the Drug Administration Law Issued	2022-02-25
Industry	Guideline on Clinical Trials of Antiviral New Drugs for Coronavirus Disease 2019 (Trial) Issued	2022-02-18
Company	Lantern Festival \| Joyful Celebration	2022-02-16
Industry	Scientists have discovered a new method that may target secondary breast cancer that has spread to the brain.	2022-02-09
Company	Shenyang Dashan Pharmaceutical Technology Co., Ltd. wishes everyone a Happy New Year!	2022-02-01
Industry	Oral Multi-Kinase Inhibitor Abandoned by Gilead Succeeds in Pivotal Phase 3 Trial	2022-01-28
Company	Shenyang Dasan Pharmaceutical Donates Supplies to Baita Subdistrict Office in Hunnan District, Shenyang	2022-01-28
Industry	NHC Notifies That Clinics and Health Stations May Use Over 500 Types of Medications	2022-01-19